Peter J. Allen

Peter J. Allen's AcademicInfluence.com Rankings

Peter J. Allen

Philosophy

#7685

World Rank

#10931

Historical Rank

Logic

#4726

World Rank

#6050

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Peter J. Allen's Degrees

Doctorate Medicine Stanford University

Why Is Peter J. Allen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter J. Allen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After (2017) (2307)
Detection and localization of surgically resectable cancers with a multi-analyte blood test (2018) (1556)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer (2017) (720)
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development (2011) (711)
Merkel cell carcinoma: prognosis and treatment of patients from a single institution. (2005) (683)
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. (2016) (616)
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. (2018) (538)
Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways (2011) (535)
Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. (2010) (452)
Impact of steatosis on perioperative outcome following hepatic resection (2003) (413)
European evidence-based guidelines on pancreatic cystic neoplasms (2018) (401)
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers (2017) (387)
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients (2015) (354)
A combination of molecular markers and clinical features improve the classification of pancreatic cysts. (2015) (339)
Pasireotide for postoperative pancreatic fistula. (2014) (335)
Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma (2017) (316)
Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases (2003) (301)
Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades (2011) (297)
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone. (2016) (260)
Preoperative Predictors for Complications after Pancreaticoduodenectomy: Impact of BMI and Body Fat Distribution (2007) (258)
Surgical management of Merkel cell carcinoma. (1999) (257)
PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue. (2008) (246)
Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas (2015) (242)
Ablation of perivascular hepatic malignant tumors with irreversible electroporation. (2012) (236)
Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. (2007) (235)
Pancreatic Adenocarcinoma: The Actual 5-Year Survivors (2008) (229)
An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions. (2011) (222)
Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. (2002) (220)
Intraductal papillary neoplasm of the bile duct: A biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? (2012) (216)
BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma. (2009) (208)
A Selective Approach to the Resection of Cystic Lesions of the Pancreas: Results From 539 Consecutive Patients (2006) (206)
Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. (2011) (205)
Serum Biomarker Panels for the Detection of Pancreatic Cancer (2011) (194)
Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas: A Clinicopathologic Analysis of 44 Cases (2014) (193)
Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting. (2016) (188)
The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. (2012) (180)
Laparoscopic Versus Open Subtotal Gastrectomy for Adenocarcinoma: A Case–Control Study (2009) (177)
Prognostic Significance of Pathologic Nodal Status in Patients with Resected Pancreatic Cancer (2007) (175)
Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. (2008) (175)
Laparoscopic distal pancreatectomy: evolution of a technique at a single institution. (2010) (175)
Distal pancreatectomy: a single institution's experience in open, laparoscopic, and robotic approaches. (2015) (174)
Accurate Staging for Gallbladder Cancer: Implications for Surgical Therapy and Pathological Assessment (2011) (171)
Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma (2008) (170)
Solid Pseudopapillary Tumors of the Pancreas. Clinical Features, Surgical Outcomes, and Long-Term Survival in 45 Consecutive Patients from a Single Center (2011) (165)
Minimally-invasive vs open pancreaticoduodenectomy: systematic review and meta-analysis. (2014) (164)
Feasibility and Yield of Screening in Relatives From Familial Pancreatic Cancer Families (2011) (158)
Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. (2007) (156)
Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? (2015) (155)
Five Hundred Patients With Merkel Cell Carcinoma Evaluated at a Single Institution (2011) (153)
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms (2018) (151)
A Retrospective Comparison of Microwave Ablation vs. Radiofrequency Ablation for Colorectal Cancer Hepatic Metastases (2014) (149)
Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant. (2016) (148)
Operative Drainage Following Pancreatic Resection: Analysis of 1122 Patients Resected Over 5 Years at a Single Institution (2013) (144)
Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. (2005) (141)
Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons. (2019) (141)
Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. (2015) (140)
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype (2017) (138)
Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. (2009) (137)
Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? (2007) (137)
Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case–Control Study (2016) (135)
GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma. (2015) (134)
FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma (2015) (131)
Hepatic Parenchymal Preservation Surgery: Decreasing Morbidity and Mortality Rates in 4,152 Resections for Malignancy (2014) (130)
Adequate Lymph Node Assessment for Extrahepatic Bile Duct Adenocarcinoma (2010) (129)
KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases (2014) (126)
A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma (2014) (122)
Laparoscopic versus Open Liver Resection: A Matched-Pair Case Control Study (2009) (122)
Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients (2003) (117)
Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone (2016) (117)
Actual 10‐year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? (2018) (116)
Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. (2015) (113)
Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy. (2011) (111)
A Matched Case-Control Study of Preoperative Biliary Drainage in Patients with Pancreatic Adenocarcinoma: Routine Drainage Is Not Justified (2009) (109)
Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 Pathway. (2010) (108)
Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma (2016) (108)
Cyst Fluid Interleukin-1β (IL1β) Levels Predict the Risk of Carcinoma in Intraductal Papillary Mucinous Neoplasms of the Pancreas (2011) (108)
Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma (2001) (107)
Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. (2008) (105)
Invasive Carcinoma Arising in Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Matched Control Study with Conventional Pancreatic Ductal Adenocarcinoma (2011) (105)
Relationship Between Intraoperative Fluid Administration and Perioperative Outcome After Pancreaticoduodenectomy: Results of a Prospective Randomized Trial of Acute Normovolemic Hemodilution Compared With Standard Intraoperative Management (2010) (103)
Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. (2011) (101)
Comparison of Adjuvant Systemic Chemotherapy With or Without Hepatic Arterial Infusional Chemotherapy After Hepatic Resection for Metastatic Colorectal Cancer (2011) (101)
Long‐term outcomes following microwave ablation for liver malignancies (2015) (99)
A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers (2012) (99)
Malignant Progression in IPMN: A Cohort Analysis of Patients Initially Selected for Resection or Observation (2013) (97)
Polypoid lesions of the gallbladder: diagnosis and followup. (2009) (97)
GFRα1 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling (2014) (97)
Pancreatic Cyst Fluid and Serum Mucin Levels Predict Dysplasia in Intraductal Papillary Mucinous Neoplasms of the Pancreas (2010) (95)
A multimodality test to guide the management of patients with a pancreatic cyst (2019) (94)
Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis. (2017) (92)
Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. (2015) (92)
Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models. (2016) (91)
Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. (2015) (90)
Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection (2016) (90)
Contemporary experience with postpancreatectomy hemorrhage: results of 1,122 patients resected between 2006 and 2011. (2012) (88)
Defining Surgical Indications for Type I Gastric Carcinoid Tumor (2009) (88)
Response to Neoadjuvant Chemotherapy Does Not Predict Overall Survival for Patients With Synchronous Colorectal Hepatic Metastases (2009) (88)
Robotic Liver Resection: A Case-Matched Comparison (2016) (88)
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial. (2019) (86)
Biobanking of Human Pancreas Cancer Tissue: Impact of Ex-Vivo Procurement Times on RNA Quality (2010) (85)
Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium (2018) (85)
Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis (2018) (85)
Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. (2013) (84)
Attenuation of the Retinoblastoma Pathway in Pancreatic Neuroendocrine Tumors Due to Increased Cdk4/Cdk6 (2012) (83)
Is Port Site Resection Necessary in the Surgical Management of Gallbladder Cancer? (2012) (83)
Single-incision laparoscopic liver resection (2011) (82)
Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases (2018) (82)
Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated (2017) (82)
Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma (2012) (80)
Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. (2014) (79)
Biliary Self-Expandable Metal Stents Do Not Adversely Affect Pancreaticoduodenectomy (2013) (79)
Predicting Dysplasia and Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Development of a Preoperative Nomogram (2013) (79)
Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients (2016) (78)
Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience. (2013) (77)
The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma (2006) (75)
Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract (2009) (74)
Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma (2017) (74)
Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy. (2013) (74)
Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization. (2017) (74)
Electronic synoptic operative reporting: assessing the reliability and completeness of synoptic reports for pancreatic resection. (2010) (74)
The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas (2006) (73)
Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection (2015) (73)
Antiangiogenic Therapy for Primary Liver Cancer: Correlation of Changes in Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Tissue Hypoxia Markers and Clinical Response (2011) (72)
T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases. (2010) (72)
Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer. (2016) (70)
Endoscopic ultrasound-guided transmural drainage of postoperative pancreatic collections. (2014) (70)
Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients. (2018) (70)
Prediagnostic Serum Biomarkers as Early Detection Tools for Pancreatic Cancer in a Large Prospective Cohort Study (2014) (69)
The role of laparoscopic staging in patients with incidental gallbladder cancer. (2011) (69)
Failure Patterns in Resected Pancreas Adenocarcinoma: Lack of Predicted Benefit to SMAD4 Expression (2013) (69)
Evaluation of Cyst Fluid CEA Analysis in the Diagnosis of Mucinous Cysts of the Pancreas (2010) (68)
The surgical management of metastatic melanoma (2002) (68)
CT radiomics to predict high‐risk intraductal papillary mucinous neoplasms of the pancreas (2018) (68)
The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer (2018) (68)
Value of Frozen-Section Analysis of Sentinel Lymph Nodes for Primary Cutaneous Malignant Melanoma (2002) (67)
Synchronous Resection of Primary and Liver Metastases for Neuroendocrine Tumors (2012) (67)
Combined Ablation and Resection (CARe) as an Effective Parenchymal Sparing Treatment for Extensive Colorectal Liver Metastases (2014) (67)
Allergies, obesity, other risk factors and survival from pancreatic cancer (2010) (67)
Management of peripancreatic fluid collections following partial pancreatectomy: a comparison of percutaneous versus EUS-guided drainage (2013) (66)
Pathologic Grade and Tumor Size are Associated with Recurrence-Free Survival in Patients with Duodenal Neuroendocrine Tumors (2014) (65)
Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases (2017) (64)
Updated long‐term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy (2016) (64)
The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes (2016) (63)
The management of variant arterial anatomy during hepatic arterial infusion pump placement (2002) (63)
The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study (2017) (62)
Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models. (2015) (61)
Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients (2017) (60)
Biliary Sclerosis after Hepatic Arterial Infusion Pump Chemotherapy for Patients with Colorectal Cancer Liver Metastasis: Incidence, Clinical Features, and Risk Factors (2012) (60)
Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer. (2014) (59)
Resection of Adrenocortical Carcinoma Liver Metastasis: Is it Justified? (2012) (59)
Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome (2017) (58)
Pathologic Response to Preoperative Chemotherapy in Colorectal Liver Metastases: Fibrosis, not Necrosis, Predicts Outcome (2012) (58)
Goal-Directed Fluid Therapy Using Stroke Volume Variation for Resuscitation after Low Central Venous Pressure-Assisted Liver Resection: A Randomized Clinical Trial. (2015) (58)
Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results (2011) (58)
Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (⩽20-mm Invasive Component): A Multi-institutional Analysis (2016) (57)
Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort (2017) (55)
Weight Loss, Diabetes, Fatigue, and Depression Preceding Pancreatic Cancer (2016) (55)
Desmoid tumors of the chest wall. (1999) (54)
Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms. (2013) (53)
Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases (2013) (53)
The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis. (2012) (53)
Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer. (2010) (53)
Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma (2017) (52)
Predicting recurrence patterns after resection of hepatocellular cancer. (2014) (52)
Pancreatic Cyst Fluid Protein Expression Profiling for Discriminating Between Serous Cystadenoma and Intraductal Papillary Mucinous Neoplasm (2009) (52)
Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma (2016) (51)
Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes. (2017) (51)
Comparison Between Perioperative and Postoperative Chemotherapy After Potentially Curative Hepatic Resection for Metastatic Colorectal Cancer (2013) (50)
Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation (2019) (50)
Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer. (2018) (49)
Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor (2016) (49)
Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease (2011) (48)
Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis. (2013) (48)
Impact of Obesity and Body Fat Distribution on Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma (2012) (48)
Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential (2018) (48)
Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma (2017) (47)
Management of hepatocellular adenoma: comparison of resection, embolization and observation. (2013) (47)
CXCR4 Expression Predicts Patient Outcome and Recurrence Patterns after Hepatic Resection for Colorectal Liver Metastases (2012) (46)
Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study. (2015) (45)
Tumor MHC Class I Expression Improves the Prognostic Value of T-cell Density in Resected Colorectal Liver Metastases (2014) (45)
Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma (2021) (45)
Current management of cystic neoplasms of the pancreas. (2008) (45)
Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. (2008) (44)
Readmission After Pancreatic Resection: Causes and Causality Pattern (2014) (44)
Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer (2017) (44)
Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance (2011) (44)
Prospective Randomized Controlled Trial of Liberal Vs Restricted Perioperative Fluid Management in Patients Undergoing Pancreatectomy (2016) (44)
American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions. (2014) (44)
Patterns of Recurrence After Ablation of Colorectal Cancer Liver Metastases (2012) (43)
Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes (2015) (43)
Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage (2015) (43)
Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT. (2014) (43)
Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance?: Results of 3024 Patients Evaluated at a Single Institution (2017) (43)
Detailed Pathologic Characteristics of the Primary Colorectal Tumor Independently Predict Outcome after Hepatectomy for Metastases (2012) (43)
Hepatic Pedicle Clamping During Hepatic Resection for Colorectal Liver Metastases: No Impact on Survival or Hepatic Recurrence (2012) (42)
Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases (2015) (42)
Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease (2015) (41)
Internal hernia after gastrectomy for cancer with Roux-Y reconstruction. (2013) (41)
Renal function after low central venous pressure-assisted liver resection: assessment of 2116 cases. (2015) (40)
ID1 mediates escape from TGF-β tumor suppression in pancreatic cancer. (2019) (40)
Minimally invasive distal pancreatectomy. (2017) (40)
Conversion to Complete Resection and/or Ablation Using Hepatic Artery Infusional Chemotherapy in Patients with Unresectable Liver Metastases from Colorectal Cancer: A Decade of Experience at a Single Institution (2013) (38)
Positive Postoperative CEA is a Strong Predictor of Recurrence for Patients After Resection for Colorectal Liver Metastases (2015) (37)
Specific Glycoforms of MUC5AC and Endorepellin Accurately Distinguish Mucinous from Nonmucinous Pancreatic Cysts* (2013) (37)
Gold nanoparticles provide bright long-lasting vascular contrast for CT imaging. (2013) (37)
Colon sentinel lymph node mapping: practical surgical applications. (2005) (37)
Floxuridine Hepatic Arterial Infusion Associated Biliary Toxicity Is Increased by Concurrent Administration of Systemic Bevacizumab (2014) (36)
Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas (2017) (36)
The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial (2017) (36)
A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases (2016) (35)
Health-Related Quality of Life After Pancreatectomy: Results From a Randomized Controlled Trial (2016) (35)
Current status of hepatic resection. (2003) (35)
Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis. (2013) (35)
Impact of pre-operative positron emission tomography in gallbladder cancer. (2014) (34)
Changes in the management of benign liver tumours: an analysis of 285 patients. (2013) (34)
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors (2019) (34)
Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases (2017) (34)
Regional Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Potential Role for Dynamic Magnetic Resonance Imaging as an Imaging Biomarker and a Survival Update from Two Prospective Clinical Trials (2014) (33)
Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. (2012) (33)
Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer (2012) (33)
Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis. (2019) (33)
CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma (2019) (32)
Clinical Features and Outcome of Primary Pancreatic Lymphoma (2015) (32)
Pancreatic adenocarcinoma in a young patient population—12‐year experience at Memorial Sloan Kettering Cancer Center (2009) (32)
Kinetics of liver volume changes in the first year after portal vein embolization. (2010) (32)
Prognostic Impact of RT-PCR-Based Detection of Peritoneal Micrometastases in Patients with Pancreatic Cancer Undergoing Curative Resection (2009) (32)
The management of intraductal papillary mucinous neoplasms of the pancreas. (2010) (32)
Regional differences in gallbladder cancer pathogenesis: Insights from a multi‐institutional comparison of tumor mutations (2018) (31)
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma. (2020) (31)
Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens (2015) (31)
The role of surgery for patients with metastatic melanoma (2002) (30)
Recurrence patterns following irreversible electroporation for hepatic malignancies (2017) (30)
Synthesis, characterization, and functionalization of gold nanoparticles for cancer imaging. (2010) (29)
Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection. (2017) (29)
Gene Expression Profiles Accurately Predict Outcome Following Liver Resection in Patients with Metastatic Colorectal Cancer (2013) (29)
Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors. (2019) (29)
Intensity modulated radiation therapy reduces gastrointestinal toxicity in locally advanced pancreas cancer. (2016) (29)
Incidentally Discovered Pancreatic Intraepithelial Neoplasia: What Is Its Clinical Significance? (2013) (29)
Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation. (2016) (29)
Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer. (2014) (29)
Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. (2016) (28)
Treatment of Extensive Metastatic Colorectal Cancer to the Liver with Systemic and Hepatic Arterial Infusion Chemotherapy and Two-Stage Hepatic Resection: The Role of Salvage Therapy for Recurrent Disease (2014) (28)
Pancreatic metastasectomy: The Memorial Sloan‐Kettering experience and a review of the literature (2014) (28)
Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing (2018) (27)
Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer (2019) (27)
Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection Versus Observation (2015) (27)
RT-PCR Increases Detection of Submicroscopic Peritoneal Metastases in Gastric Cancer and Has Prognostic Significance (2011) (26)
Segment and fit thresholding: a new method for image analysis applied to microarray and immunofluorescence data. (2015) (26)
Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection* (2017) (25)
Pitfalls in avoiding operation for autoimmune pancreatitis. (2011) (25)
Timing of elective surgery as a perioperative outcome variable: analysis of pancreaticoduodenectomy. (2014) (25)
Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN) (2018) (24)
A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas (2016) (24)
Role of staging laparoscopy in peri-pancreatic and hepatobiliary malignancy. (2010) (24)
Initial report of laparoscopic celiac plexus block for pain relief in patients with unresectable pancreatic cancer. (2006) (24)
Intraductal Oncocytic Papillary Neoplasms: Clinical-Pathologic Characterization of 24 Cases, With An Emphasis on Associated Invasive Carcinomas (2019) (23)
Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report (2016) (22)
A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients (2016) (22)
32nd Annual Meeting and Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2017): Part One (2017) (22)
Cystic Neoplasms of the Pancreas. (2016) (22)
Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative procedures and in-hospital days? (2012) (22)
Prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas. (2010) (21)
Hepatic Arterial Nodal Metastases in Pancreatic Cancer: Is This the Node of Importance? (2013) (21)
Operative morbidity and survival following hepatectomy for colorectal liver metastasis in octogenarians: a contemporary case matched series. (2016) (21)
Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies (2017) (20)
Premalignant cystic neoplasms of the pancreas. (2015) (20)
Detection of Micrometastases in Peritoneal Washings of Pancreatic Cancer Patients by the Reverse Transcriptase Polymerase Chain Reaction (2007) (20)
Cystic lesions of the pancreas: Selection criteria for operative and non-operative management in 209 patients (2003) (20)
Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges (2018) (20)
Pharmacologic Prophylaxis, Postoperative INR, and Risk of Venous Thromboembolism after Hepatectomy (2014) (20)
Herpes Simplex Virus (HSV)-Mediated ICAM-1 Gene Transfer Abrogates Tumorigenicity and Induces Anti-Tumor Immunity (1999) (20)
The effects of hepatic cryosurgery on tumor growth in the liver. (1998) (20)
Liberal resection for (presumed) Sendai negative branch-duct intraductal papillary mucinous neoplasms--also not harmless. (2014) (19)
Central hepatectomy versus extended hepatectomy for liver malignancy: a matched cohort comparison. (2015) (19)
Outcomes after Pancreatectomy with Routine Pasireotide Use. (2019) (19)
High-grade dysplasia of the cystic duct margin in the absence of malignancy after cholecystectomy. (2011) (18)
Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance ? luated at a Single Institution Results of 3024 Patients (2017) (18)
Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. (2013) (18)
Surgical Treatment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement by Evans et al. (2009) (17)
Histopathological growth patterns and positive margins after resection of colorectal liver metastases. (2018) (17)
Utility of a Prognostic Nomogram Designed for Gastric Cancer in Predicting Outcome of Patients with R0 Resected Duodenal Adenocarcinoma (2007) (17)
Prospective Evaluation of Laparoscopic Celiac Plexus Block in Patients with Unresectable Pancreatic Adenocarcinoma (2011) (17)
Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients. (2019) (16)
Psychometric Validation of the EORTC QLQ-PAN26 Pancreatic Cancer Module for Assessing Health Related Quality of Life after Pancreatic Resection (2017) (16)
Lower extremity lymphedema caused by acquired immune deficiency syndrome-related Kaposi's sarcoma: case report and review of the literature. (1995) (16)
Saphenous vein versus polytetrafluoroethylene carotid patch angioplasty. (1997) (16)
The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma. (2017) (16)
O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors. (2017) (16)
c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival. (2013) (16)
Recurrence rate and pattern of perihilar cholangiocarcinoma after curative intent resection (2016) (15)
Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome (2014) (15)
Hospital readmissions after liver surgery for metastatic colorectal cancer. (2015) (14)
The management of cystic lesions of the pancreas. (2007) (14)
Hypophosphatemia after Hepatectomy or Pancreatectomy: Role of the Nicotinamide Phosphoribosyltransferase. (2017) (14)
Validation of the 8th Edition American Joint Commission on Cancer (AJCC) Gallbladder Cancer Staging System: Prognostic Discrimination and Identification of Key Predictive Factors (2021) (14)
Early trends in serum phosphate and creatinine levels are associated with mortality following major hepatectomy. (2015) (14)
Perioperative Bundle to Reduce Surgical Site Infection after Pancreaticoduodenectomy: A Prospective Cohort Study. (2019) (13)
The accuracy of pre-operative imaging in the management of hepatic cysts. (2015) (13)
Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection. (2019) (13)
3D image guidance assisted identification of colorectal cancer liver metastases not seen on intraoperative ultrasound: results from a prospective trial. (2017) (13)
Uncinate Duct Dilation in Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Radiographic Finding with Potentially Increased Malignant Potential (2014) (13)
Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver Metastases (2020) (13)
Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm. (2016) (12)
Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach? (2019) (12)
Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma (2021) (12)
Pancreatic adenocarcinoma: putting a hump in survival. (2007) (12)
Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: the Memorial Sloan Kettering Cancer Center experience. (2016) (12)
Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer (2016) (12)
Contributions from surgeons to clinical trials and research on the management of soft tissue sarcoma (1998) (12)
Operative drains after pancreatic resection--the Titanic is sinking. (2011) (12)
The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma (2016) (12)
The diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas: has progress been made? (2019) (11)
Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes (2018) (11)
ACR Appropriateness Criteria® Staging of Pancreatic Ductal Adenocarcinoma. (2017) (11)
Pasireotide for postoperative pancreatic fistula. (2014) (11)
A perioperative multidisciplinary care bundle reduces surgical site infections in patients undergoing synchronous colorectal and liver resection. (2019) (11)
Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution. (2019) (11)
Human Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the Staging of Pancreatic Cancer (2016) (11)
Risk of Occult Irresectable Disease at Liver Resection for Hepatic Colorectal Cancer Metastases: A Contemporary Analysis (2013) (11)
Therapeutic Approach to Cystic Neoplasms of the Pancreas. (2016) (11)
Resolution of Hepatic Encephalopathy Following Hepatic Artery Embolization in a Patient with Well-Differentiated Neuroendocrine Tumor Metastatic to the Liver (2010) (11)
Recurrence Patterns of Intraductal Papillary Mucinous Neoplasms of the Pancreas on Enhanced Computed Tomography (2009) (11)
A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma (2018) (10)
Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. (2019) (10)
Use of Intraoperative Ablation as an Adjunct to Surgical Resection in the Treatment of Recurrent Colorectal Liver Metastases (2011) (10)
Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA (2020) (10)
Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease (2012) (10)
Reply to Letter: "Operative Drainage Following Pancreatic Resections: We Need More Evidence". (2015) (10)
Resection of perihilar biliary schwannoma. (2011) (10)
Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype–Phenotype Features—An Entity With an Increasing Incidence? (2018) (9)
Simple mucinous cysts of the pancreas have heterogeneous somatic mutations. (2020) (9)
Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging. (2018) (9)
Pilot study of rapid MR pancreas screening for patients with BRCA mutation (2019) (9)
Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases (2018) (9)
Quantification of CT images for the classification of high- and low-risk pancreatic cysts (2017) (9)
Is minimally invasive surgery of lesions in the right superior segments of the liver justified? A multi‐institutional study of 245 patients (2020) (8)
O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors. (2017) (8)
Operative Resection is Currently Overutilized for Cystic Lesions of the Pancreas (2013) (8)
Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative study. (2020) (8)
Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms (2020) (7)
Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers (2012) (7)
Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? (2022) (7)
Prognostic Significance of the Highest Peripancreatic Lymph Node in Biliary Tract Adenocarcinoma (2014) (7)
Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. (2012) (7)
The diagnosis and management of cystic lesions of the pancreas. (2017) (7)
Evolving application of minimally invasive cancer operations at a tertiary cancer center (2017) (7)
Comparison of surgical and endoscopic sample collection for pancreatic cyst fluid biomarker identification. (2012) (7)
Liver angiomyolipomas: a clinical, radiologic, and pathologic analysis of 22 patients from a single center. (2011) (7)
Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas (2017) (7)
Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy (2020) (6)
Symptomatic Perihepatic Fluid Collections After Hepatic Resection in the Modern Era (2016) (6)
A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer. (2016) (6)
Randomized clinical trials in pancreatic adenocarcinoma. (2010) (6)
Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas (2017) (6)
Vascular inflow control during hemi-hepatectomy: a comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation. (2013) (6)
Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2 (2019) (6)
Hepatic steatosis is associated with increased complications following major liver resection for cancer but does not impact survival (2003) (6)
Texture analysis for survival prediction of pancreatic ductal adenocarcinoma patients with neoadjuvant chemotherapy (2016) (6)
A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC). (2018) (6)
Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms (2021) (6)
968 Performance Characteristics of Cyst Fluid CEA Analysis for the Diagnosis of Mucinous Cysts of the Pancreas (2009) (6)
Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases (2018) (6)
Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer (2021) (5)
Can physician gestalt predict survival in patients with resectable pancreatic adenocarcinoma? (2018) (5)
Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases (2019) (5)
Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients (2018) (5)
Malignant progression in intraductal papillary mucinous neoplasms of the pancreas: Results of 157 patients selected for radiographic surveillance. (2012) (5)
MGMT immunohistochemistry (IHC) and exclusion of pancreatic NET (PanNET) patients from treatment with temozolomide-based therapy. (2014) (4)
Cyst Fluid Analysis in Pancreatic Intraductal Papillary Mucinous Neoplasms (2016) (4)
Pancreatic neuroendocrine tumors: Can the WHO staging system be simplified (2007) (4)
T1377 Pancreatic Cyst Fluid CEA Concentration >1000 NG/Ml is Not an Indicator of Malignancy (2010) (4)
Short-Term Risk of Performing Concurrent Procedures with Hepatic Artery Infusion Pump Placement (2020) (4)
Prospective assessment for pathogenic germline alterations (PGA) in pancreas cancer (PAC). (2017) (4)
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases. (2015) (4)
Quantitative Computed Tomography Image Analysis to Predict Pancreatic Neuroendocrine Tumor Grade. (2021) (4)
Intraductal papillary neoplasm of the bile duct (IPNB): A biliary equivalent to IPMN of the pancreas? (2011) (4)
Metastatic carcinoid tumour presenting as hepatic encephalopathy. (2002) (4)
Postoperative liver failure risk score identifying patients with resectable perihilar cholangiocarcinoma who may benefit from portal vein embolization (2019) (3)
Imaging comparison of tubular and colloid pancreatic adenocarcinoma arising from intraductal papillary mucinous neoplasm on multidetector CT. (2016) (3)
Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients. (2020) (3)
Right versus left: Impact of primary location on survival and cure in patients undergoing hepatic resection for metastatic colon cancer. (2017) (3)
Advances in the management of pancreatic cystic neoplasms. (2020) (3)
Prospective Phase II Trial of Combination Hepatic Artery and Systemic Chemotherapy for Unresectable Colorectal Liver Metastases: Long-Term Results and Curative Potential (2016) (3)
Early liver metastases after "failure" of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy? (2020) (3)
Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery (2020) (3)
Survival after resection plus intra-operative radiofrequency ablation (IRFA) to treat colorectal liver metastases (CLM): Results of an international collaborative study. (2013) (3)
Studying cancer in minorities (2011) (3)
Lending a hand for laparoscopic distal pancreatectomy: the optimal approach? (2019) (3)
Levels of Evidence in Medical Research: "Bigger Is Not Always Better". (2017) (3)
Association of KRAS mutation with worse recurrence-free survival and site of metastatic progression after resection of hepatic colorectal metastases. (2013) (2)
Cystic Lesions of the Pancreas: Observe or Operate (2015) (2)
148 Biliary Self Expandable Metal Stents Do Not Increase Overall Complications in Patients Undergoing Pancreaticoduodenectomy (2012) (2)
Detection of Chemotherapy-Resistant Pancreatic Cancer Using a Glycan Biomarker (2020) (2)
Chapter 66 – Techniques of pancreatic resection: Pancreaticoduodenectomy, distal pancreatectomy, segmental pancreatectomy, total pancreatectomy, and transduodenal resection of the papilla of vater (2017) (2)
The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study (2017) (2)
Treatment of pancreatic cancer by intra-arterial injection of an emulsion of Lipiodol and bumetanide (an anti-glycolytic drug) in a porcine model: initial results (2017) (2)
Synchronous epithelial and neuroendocrine cancers of the pancreas: case series of a rare occurrence. (2011) (2)
Improvement in long-term survival in patients with metastatic colorectal cancer (CRC) after liver resection with modern chemotherapy and hepatic arterial infusion (HAI). (2015) (2)
Development of a preoperative risk score for postoperative mortality after liver resection for presumed perihilar cholangiocarcinoma (2016) (2)
Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer: The Future Ain’t What It Used To Be (2011) (2)
T1583 A Matched Case-Control Study of Preoperative Biliary Drainage (PDB) in Patients with Pancreatic Adenocarcinoma: Routine PBD Is Not Justified (2009) (2)
Invasive central venous monitoring during hepatic resection: unnecessary for most patients. (2019) (2)
Clinical outcomes in pancreatic adenocarcinoma (PAC) in breast cancer (BC) survivors. (2010) (2)
Intensity-modulated radiation therapy (IMRT) in patients with locally advanced pancreatic cancer (LAPC). (2015) (2)
Mutational profiling of resected intrahepatic cholangiocarcinoma. (2017) (2)
Multiinstitutional Validation Study of Cyst Fluid Protein Biomarkers in Patients With Cystic Lesions of the Pancreas (2021) (2)
Response rates to hepatic arterial infusion (HAI) pump therapy in patients with metastatic colorectal cancer liver metastases (mCRC LM) after progression on all standard chemotherapies. (2014) (2)
Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients (2020) (1)
Merkel cell carcinoma : Improved outcome with the addition of adjuvant therapy. Authors' replay (2005) (1)
Sa1466 Management of Peri-Pancreatic Fluid Collections Following Non-Whipple Pancreatic Surgery: A Comparison of Percutaneous vs EUS-Guided Drainage (2011) (1)
FOLFIRINOX induction therapy for stage III pancreatic adenocarcinoma (2014) (1)
Anatomy of the Pancreas and Biliary Tree (2018) (1)
Influence of KRAS mutation on recurrence patterns in patients undergoing hepatic resection of colorectal metastases. (2013) (1)
1124 A MULTI-MODALITY TEST TO GUIDE THE MANAGEMENT OF PATIENTS WITH PANCREATIC CYSTS (2019) (1)
Current Controversy of Radiographic Surveillance of Patients With Branch-duct IPMN and Pancreatic Cysts: Commentary on: Ductal Carcinoma Arising in a Largely Unchanged Presumed Branch Duct IPMN After 10 Years of Surveillance. (2017) (1)
Effect of perioperative complications on recurrence and survival after resection of hepatic colorectal metastases: Analysis of data from a randomized controlled trial. (2012) (1)
Infiltrating neutrophils and malignant progression in intraductal papillary mucinous neoplasms (IPMN): An opportunity for identification of high-risk disease. (2014) (1)
A Multicenter, Validation Study of Cyst Fluid Analysis for MAB Das-1 for the Identification of High-Risk and Malignant Mucinous Cysts of the Pancreas (2017) (1)
Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype. (2016) (1)
Clinical and Molecular Analysis of Adenosquamous Carcinoma of the Pancreas (2016) (1)
Surgical Management of IPMN Lesions of the Pancreas (2015) (1)
Chapter 57 – Cystic neoplasms of the pancreas: Epidemiology, clinical features, assessment, and management (2012) (1)
Is conversion to resection possible with hepatic arterial infusion (HAI) and systemic (SYS) even in previously treated patients (pts) with unresectable colorectal liver metastases (UnCLM) (2012) (1)
Chapter 60 - Cystic neoplasms of the pancreas: Epidemiology, clinical features, assessment, and management (2016) (1)
Abstract A71: Studying cancer in minorities: A look at the numbers (2009) (1)
Evolving Role of Drains, Tubes and Stents in Pancreatic Surgery (2018) (1)
Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma (2021) (1)
Evaluation of putative prognostic tissue biomarkers in pancreatic ductal adenocarcinoma. (2011) (1)
A Multi-Institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-Grade Dysplasia in Intraductal Papillary Mucinous Neoplasms (2016) (1)
Use of detailed pathologic characteristics of the primary colorectal tumor to predict outcome after hepatectomy for metastases. (2012) (1)
A combined radiomics and cyst fluid inflammatory markers model to predict preoperative risk in pancreatic cystic lesions (2020) (1)
Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: Does the addition of systemic bevacizumab improve results? (2011) (1)
Reply to “Totally Laparoscopic Gastrectomy: A Reality for USA and Europe?” (ASO-2009-04-0501.R1) (2009) (1)
Cancer Therapy : Preclinical Attenuation of the Retinoblastoma Pathway in Pancreatic Neuroendocrine Tumors Due to Increased Cdk 4 / Cdk 6 (2012) (1)
Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal Adenocarcinoma (2021) (1)
Quantitative CT analysis for the preoperative prediction of pathologic grade in pancreatic neuroendocrine tumors (2018) (1)
Abstract 2444: The use of CT radiomics to predict immune infiltrate in pancreatic ductal adenocarcinoma (2019) (1)
Biomarker Development in IPMN: The Problem of the Known Unknowns and the Unknown Unknowns. (2021) (1)
Clinical outcomes in pancreatic adenocarcinoma (PAC) associated with a known BRCA mutation. (2011) (1)
Fifty years of pancreas cancer care (2022) (1)
Hepatocellular carcinoma in patients with no identifiable risk factors. (2019) (1)
Endoscopic versus percutaneous drainage of post-operative fluid collection following pancreatic resection (2017) (1)
Change in circulating tumor DNA after hepatic resection for metastatic colorectal cancer (2018) (1)
Chemotherapy and Intensity Modulated Radiation Therapy for Locally Advanced Pancreatic Cancer Achieves Prolonged Survival (2014) (1)
Postoperative mortality after liver resection for perihilar cholangiocarcinoma: Importance of biliary drainage of the future liver remnant and development of a risk score (2016) (1)
1031 Natural History of Patients Followed Radiographically With Mucinous Cystic Neoplasms of the Pancreas (2016) (0)
Brain metastases (BM) in pancreatic ductal adenocarcinoma (PDAC): Clinical and molecular characteristics. (2017) (0)
Recurrence Patterns after Irreversible Electroporation for Hepatic Metastases (2016) (0)
Outcomes following transarterial embolization for hepatocellular carcinoma with complete radiologic response (2018) (0)
Tu1217 Pancreatic Cyst Fluid Concentration of High-Mobility Group A2 (HMGA2) Protein Acts As a Differential Biomarker of Dysplasia in IPMN (2013) (0)
T1915 Anti-Lewis Y Antibody As a Novel Target for Pancreatic Adenocarcinoma (2008) (0)
AB098. P072. Investigation of BRCAness in pancreatic cancer using patient-derived organoid models (2018) (0)
Patterns of recurrence and peri-operative predictors of liver metastasis after pancreatic cancer resection (2018) (0)
ASO Visual Abstract: Recurrence After Resection of Pancreatic Cancer – Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? (2022) (0)
Prospective analysis of somatic and germline genetic alterations in patients with ampullary carcinomas. (2018) (0)
Clinical utility of immunoglobulin-G4 in the diagnosis of autoimmune pancreatitis (2017) (0)
Su1530 Robotic Hepatic Artery Infusion Pump Placement (2016) (0)
Significance of CEACAM6 expression in biliary tract carcinoma. (2012) (0)
Association of adjuvant hepatic artery infusion chemotherapy after resection of colorectal liver metastases with improved survival in patients with both right- and left-sided primary tumors. (2018) (0)
Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al. (2017) (0)
AB005. S005. A multiinstitutional postoperative nomogram for disease recurrence following resection of localized G1/G2 pancreatic neuroendocrine tumors (2018) (0)
Pathology remains the most important predictor of long-term survival using a modern prognostic nomogram for resected pancreatic ductal adenocarcinoma (2019) (0)
Outcomes after pancreatectomy with routine usage of pasireotide (2018) (0)
When and How to Follow Patients with Cystic Tumors of the Pancreas (2016) (0)
Pancreaticoduodenectomy for an acth-secreting pancreatic neuroendocrine tumor in a 12 year old: case report and literature review (2020) (0)
Extraordinary survivorship after colorectal liver metastasis resection to identify a distinct molecular profile associated with survival in an independent cohort of 965 patients. (2017) (0)
Empiric nasogastric decompression after pancreaticoduodenectomy is not necessary (2019) (0)
Assessment of genomic alterations in adenosquamous carcinoma of the pancreas (ASCOP). (2016) (0)
S1985 Pancreatic Cancer Patients From Lynch Syndrome-Like Families Do Not Have Improved Overall Survival When Compared With Sporadic Pancreatic Cancer Patients (2010) (0)
How Long Should Patients with Cystic Lesions of the Pancreas Be Followed? (2018) (0)
Response to the Comment on "Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed Our Approach?: Results From a Multi-institutional Study". (2020) (0)
Quality of life in RCT of pasireotide to reduce pancreatic complications following resection. (2015) (0)
Intraductal Papillary Mucinous Neoplasm in Patients Under age 50: Tumor Biology, Clinical Features, Recurrence Rates, and Survival Outcomes (2017) (0)
Incidence and risk factors for biliary sclerosis following adjuvant hepatic arterial infusion with floxuridine after hepatectomy for metastatic colorectal cancer. (2010) (0)
A Prospective Cohort Study of a Perioperative Bundle to Reduce Surgical Site Infection following Pancreaticoduodenectomy (2021) (0)
Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC). (2011) (0)
T1462: EUS Impacts the Decision to Resect Small (≤ 3 cm), Asymptomatic Pancreatic Cystic Lesions (2010) (0)
Genomic landscape of pancreatic adenocarcinoma: Does age matter? (2016) (0)
Attenuation of the Rb pathway in Pancreatic Neuroendocrine Tumors Due to Increased Cdk 4 / Cdk 6 (2012) (0)
W1668 The use of Intraoperative Ablation Extends the Limits of Potentially Curative Treatment for Recurrent Colorectal Liver Metastases (2010) (0)
Improved mortality after pancreatectomy in the modern era (2018) (0)
597 Molecular Markers Help Define Cyst Type in the Pancreas: An International, Multicenter Study of Over 300 Cysts (2016) (0)
Iconographies supplémentaires de l'article : FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis (2016) (0)
A matched analysis comparing the epidemiology of intraductal papillary mucinous neoplasms to standard pancreatic adenocarcinoma and healthy controls. (2011) (0)
Cystic tumors of the pancreas (2010) (0)
M1289 Family History of Certain Cancers Is Not Associated with Younger Age At Diagnosis of Pancreatic Adenocarcinoma (2009) (0)
Cystic Neoplasms of the Pancreas: Diagnosis and imaging (2009) (0)
Gene expression profiles to predict outcome following liver resection in patients with metastasis of colorectal cancer. (2010) (0)
488 Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection vs. Observation (2015) (0)
Role of biliary CEACAM6 as a biomarker for cholangiocarcinoma. (2013) (0)
– BONE AND SOFT TISSUE SARCOMAS Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor (2019) (0)
Correction to: Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients (2018) (0)
Minimally invasive versus open segment 7 and 8 hepatic resection: a propensity score-matched comparison (2017) (0)
The management of small asymptomatic pancreatic neuroendocrine tumors: A matched case-control study. (2015) (0)
160. Cyst Fluid Protein Expression Profiling for the Discrimination Between Benign and Premalignant Cysts of the Pancreas (2008) (0)
Robotic completion radical cholecystectomy for incidental gallbladder cancer (2020) (0)
Conversion to complete surgical treatment using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer. (2012) (0)
Internal Hernia After Gastrectomy With Roux-Y Reconstruction for Cancer (2013) (0)
Use of CXCR4 as a prognostic marker for disease-specific survival and pattern of recurrence following resection of hepatic colorectal metastases. (2009) (0)
Empiric nasogastric decompression after pancreaticoduodenectomy is not necessary. (2021) (0)
Trans-arterial embolization for hepatocellular carcinoma: doxorubicin is not necessary (2016) (0)
Long-termOutcomes Following Tumor Ablation for Treatment of Bilateral Colorectal LiverMetastases (2013) (0)
ASO Author Reflections: Long-Term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma (2021) (0)
Health-related quality of life (HRQoL) following pancreatic resection in RCT of pasireotide. (2014) (0)
Symptomatic perihepatic collections after hepatic resection in the modern era (2014) (0)
Non-alcoholic fatty liver disease is an independent predictor of recurrence after resection of colorectal liver metastases (2019) (0)
Chapter 25 – Postoperative complications requiring intervention, diagnosis, and management (2012) (0)
Cancer of the Pancreas: Distal Resections and Staging of Pancreatic Cancer (2011) (0)
Recurrence rate and pattern after resection of colorectal liver metastases with and without hepatic arterial infusion chemotherapy (2018) (0)
913 Pharmacologic Prophylaxis, Postoperative INR, and Risk of Venous Thromboembolism After Hepatectomy (2013) (0)
M1386 Azathioprine is Effective in Maintaining Clinical, Radiographic, and Biochemical Remission in Autoimmune Pancreatitis/IgG4-Associated Cholangitis (2010) (0)
Abstract B60: Analysis of the endocytic receptor MRC2 as a target for mesenchymal pancreatic cancer cells (2013) (0)
Pancreatic adenocarcinoma (PAC) in a younger patient population: 10-year experience at Memorial Sloan-Kettering Cancer Center (MSKCC) (2008) (0)
Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging System in Patients with Intraductal Papillary Mucinous Neoplasm-Associated PDAC (2021) (0)
Regional differences in gallbladder cancer pathogenesis: Insights from a comparison of tumor mutations (2018) (0)
Resection of colorectal liver metastases after early failure of adjuvant systemic chemotherapy for the primary tumor: Is there a role for additional treatment (2018) (0)
Intensity Modulated Radiation Therapy for Locally Advanced Pancreatic Cancer Achieves High Rate of R0 Resection (2011) (0)
Hepatic arterial infusion for unresectable intrahepatic cholangiocarcinoma: An update on survival from two prospective clinical trials. (2013) (0)
Abstract PO-002: Detection of chemotherapy-resistant pancreatic cancer using a glycan Biomarker (2020) (0)
Postoperative complications and extended hospitalization impact timely initiation and completion of adjuvant therapy for pancreas cancer (2019) (0)
Adjuvant hepatic arterial infusion chemotherapy is associated with superior survival after resection of colorectal liver metastases: A propensity score analysis of 2368 patients (2016) (0)
Poor prognosis in patients with resectable KRAS-MUT colorectal liver metastases is improved by adjuvant hepatic arterial infusion chemotherapy. (2017) (0)
Sa1487 Direct Percutaneous Endoscopic Jejunostomy for Management of Severe Delayed Gastric Emptying Following Pancreatoduodenectomy (2015) (0)
A multicentre analysis on the impact of primary tumour location in patients undergoing surgery for colorectal liver metastasis. (2019) (0)
Adequate lymph node assessment for extrahepatic bile duct cancer: Do the data support the current AJCC recommendations? (2009) (0)
Recurrence rate and patterns with and without perioperative systemic chemotherapy after resection of colorectal liver metastases (2018) (0)
Abstract 4555: Protein and glycan biomarkers of malignant potential in pancreatic cyst fluid (2012) (0)
1028 Management of Symptomatic Intraabdominal Collections After 672 Hepatic Resections (2009) (0)
Multidisciplinary, perioperative care bundle decreases surgical site infection in patients undergoing synchronous colorectal/liver resection (2018) (0)
Behind the cyst: predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) by quantitative image analysis (2017) (0)
Intraductal papillary mucinous neoplasms in young patients have different epithelial subtypes and a more favorable prognosis (2017) (0)
Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage. (2023) (0)
Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome (2014) (0)
Longitudinal follow-up of a prospective phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma reveals distinct patterns of survivorship (2019) (0)
KRAS and TP53 status as a predictor of survival in patients with resected pancreatic ductal adenocarcinoma. (2019) (0)
Proteomic evaluation of biliary exosomes implicates exportin7 in the pathogenesis of extrahepatic cholangiocarcinoma (2017) (0)
Vascular inflow control during hepatic lobectomy: a comparison of intrahepatic pedicle ligation versus extrahepatic ligation (2003) (0)
ASO Author Reflections: Progression after Resection of Noninvasive or Microinvasive Intraductal Papillary Mucinous Neoplasms (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Peter J. Allen?

Peter J. Allen is affiliated with the following schools:

University of Medicine and Dentistry of New Jersey
Duke University
University of Illinois Chicago